Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

43.00p

Change Today:

-4.70p
52 Week High: 77.40
52 Week Low: 26.60

Currency: UK Pounds
Shares Issued: 72.59m
Volume: 270,827

Market Cap: £31.21m
RiskGrade: 453
Beta: 0.02

Trade now with Barclays Stockbrokers

Update - Novacyt S.A. (CDI) is down today can you capitalise from spread betting? Find out more
Update - Novacyt S.A. (CDI) is near the bottom of the FTSE AIM - will it stay here? Have a look at Novacyt S.A. (CDI)'s chart Find out more
Update - Novacyt S.A. (CDI) is a top faller in its sector - can you take advantage with spread betting? Find out more

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart (19-08-2026)

6 Month Chart

More Novacyt S.A. (CDI) charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-128.8%	n/a
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	1.4	n/a
Pr/Book	1.2

	Latest	F'cast
Revenue	2.0%	n/a
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

NCYT Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	92.60	(5.66)	(9.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	21.04	(20.05)	(31.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	10.62	(24.46)	(34.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	19.63	(39.73)	(55.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	20.03	(27.35)	(33.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Company Announcements

No recent information was found.

NCYT ShareCast News

Novacyt agrees to acquire Southern Cross Diagnos...	23-Feb-2026	ShareCast
Novacyt flags improved second-half performance	22-Oct-2025	ShareCast
Novacyt subsidiary fined for HSE breach at 'hist...	12-Sep-2025	ShareCast

More Novacyt S.A. (CDI) ShareCast news

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

NCYT Market Data

Currency	UK Pounds
Share Price	43.00p
Change Today	-4.70p
% Change	-9.85 %
52 Week High	77.40
52 Week Low	26.60
Volume	270,827
Shares Issued	72.59m
Market Cap	£31.21m
Beta	0.02
RiskGrade	453